Home > News > BASF Venture Capital invests in North American investment fund ARCH Venture Fund VII
December 12th, 2007
BASF Venture Capital invests in North American investment fund ARCH Venture Fund VII
BASF Venture Capital America Inc., Fremont, CA, has invested in ARCH Venture Fund VII - a venture capital fund managed by ARCH Venture Partners, Chicago, IL. ARCH invests at a very early stage in start-up companies from the material science, life science, as well as information technology and biotechnology sectors in North America. The majority of these start-ups have been spun off from universities or national research laboratories. The total volume of the ARCH fund will be roughly $400 million fund. BASF Venture Capital will invest $5 million. Other investors in the fund are primarily universities, pension funds and financial institutions.
"ARCH is one of the most-respected venture capital funds in the U.S., supported by an impressive management team. ARCH will complement our strategy of investing in innovative companies that are active in BASF Group's five growth clusters - energy management, raw material change, nanotechnology plant biotechnology and white (industrial) biotechnology," said Keith Gillard, Principal of BASF Venture Capital America.
Harris & Harris Group Invests in Unique NYC Biotech Accelerator July 29th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014
Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014
NanoScience: Giants of the Infinitesimal July 31st, 2014
Nature inspires a greener way to make colorful plastics July 30th, 2014
Analytical solutions from Malvern Instruments support University of Wisconsin-Milwaukee researchers in understanding environmental effects of nanomaterials July 30th, 2014
FEI Unveils New Solutions for Faster Time-to-Analysis in Metals Research July 30th, 2014